Advertisement
Loading...

Senzime AB (publ)

SNZZFPNK
Healthcare
Medical - Devices
$0.48
$0.00(0.00%)
U.S. Market opens in 11h 0m

Senzime AB (publ) Fundamental Analysis

Senzime AB (publ) (SNZZF) shows moderate financial fundamentals with a PE ratio of -5.59, profit margin of -1.20%, and ROE of -38.22%. The company generates $0.1B in annual revenue with strong year-over-year growth of 77.89%.

Key Strengths

Cash Position73.78%
PEG Ratio-0.03
Current Ratio3.76

Areas of Concern

ROE-38.22%
Operating Margin-1.17%
We analyze SNZZF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -80.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-80.3/100

We analyze SNZZF's fundamental strength across five key dimensions:

Efficiency Score

Weak

SNZZF struggles to generate sufficient returns from assets.

ROA > 10%
-35.61%

Valuation Score

Excellent

SNZZF trades at attractive valuation levels.

PE < 25
-5.59
PEG Ratio < 2
-0.03

Growth Score

Moderate

SNZZF shows steady but slowing expansion.

Revenue Growth > 5%
77.89%
EPS Growth > 10%
4.12%

Financial Health Score

Excellent

SNZZF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.08
Current Ratio > 1
3.76

Profitability Score

Weak

SNZZF struggles to sustain strong margins.

ROE > 15%
-3821.61%
Net Margin ≥ 15%
-1.20%
Positive Free Cash Flow
No

Key Financial Metrics

Is SNZZF Expensive or Cheap?

P/E Ratio

SNZZF trades at -5.59 times earnings. This suggests potential undervaluation.

-5.59

PEG Ratio

When adjusting for growth, SNZZF's PEG of -0.03 indicates potential undervaluation.

-0.03

Price to Book

The market values Senzime AB (publ) at 2.46 times its book value. This may indicate undervaluation.

2.46

EV/EBITDA

Enterprise value stands at -8.22 times EBITDA. This is generally considered low.

-8.22

How Well Does SNZZF Make Money?

Net Profit Margin

For every $100 in sales, Senzime AB (publ) keeps $-1.20 as profit after all expenses.

-1.20%

Operating Margin

Core operations generate -1.17 in profit for every $100 in revenue, before interest and taxes.

-1.17%

ROE

Management delivers $-38.22 in profit for every $100 of shareholder equity.

-38.22%

ROA

Senzime AB (publ) generates $-35.61 in profit for every $100 in assets, demonstrating efficient asset deployment.

-35.61%

Following the Money - Real Cash Generation

Operating Cash Flow

Senzime AB (publ) generates limited operating cash flow of $-100.00M, signaling weaker underlying cash strength.

$-100.00M

Free Cash Flow

Senzime AB (publ) generates weak or negative free cash flow of $-108.95M, restricting financial flexibility.

$-108.95M

FCF Per Share

Each share generates $-0.69 in free cash annually.

$-0.69

FCF Yield

SNZZF converts -15.64% of its market value into free cash.

-15.64%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.59

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.03

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.46

vs 25 benchmark

P/S Ratio

Price to sales ratio

6.73

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.08

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.76

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.38

vs 25 benchmark

ROA

Return on assets percentage

-0.36

vs 25 benchmark

ROCE

Return on capital employed

-0.38

vs 25 benchmark

How SNZZF Stacks Against Its Sector Peers

MetricSNZZF ValueSector AveragePerformance
P/E Ratio-5.5929.24 Better (Cheaper)
ROE-38.22%713.00% Weak
Net Margin-120.41%-42604.00% (disorted) Weak
Debt/Equity0.080.46 Strong (Low Leverage)
Current Ratio3.764.36 Strong Liquidity
ROA-35.61%-16668.00% (disorted) Weak

SNZZF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Senzime AB (publ)'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

331.65%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-12.22%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-10.26%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ